Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
53,788,752
-
Total 13F shares
-
189,088
-
Share change
-
+4,245
-
Total reported value
-
$823,550
-
Price per share
-
$4.34
-
Number of holders
-
12
-
Value change
-
+$18,066
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) as of Q4 2022
As of 31 Dec 2022,
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
189,088 shares.
The largest 10 holders included
Northeast Financial Consultants Inc, IEQ CAPITAL, LLC, BANK OF AMERICA CORP /DE/, CLARET ASSET MANAGEMENT Corp, FIDUCIARY TRUST CO, JPMORGAN CHASE & CO, MORGAN STANLEY, UBS Group AG, Royal Bank of Canada, and GABLES CAPITAL MANAGEMENT INC..
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.